JP2004529960A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529960A5
JP2004529960A5 JP2002590991A JP2002590991A JP2004529960A5 JP 2004529960 A5 JP2004529960 A5 JP 2004529960A5 JP 2002590991 A JP2002590991 A JP 2002590991A JP 2002590991 A JP2002590991 A JP 2002590991A JP 2004529960 A5 JP2004529960 A5 JP 2004529960A5
Authority
JP
Japan
Prior art keywords
hydroxy
alkyl
halogen
compound
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002590991A
Other languages
English (en)
Japanese (ja)
Other versions
JP4597481B2 (ja
JP2004529960A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2002/004768 external-priority patent/WO2002094274A1/en
Publication of JP2004529960A publication Critical patent/JP2004529960A/ja
Publication of JP2004529960A5 publication Critical patent/JP2004529960A5/ja
Application granted granted Critical
Publication of JP4597481B2 publication Critical patent/JP4597481B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002590991A 2001-05-18 2002-05-17 下剤組成物 Expired - Lifetime JP4597481B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29163501P 2001-05-18 2001-05-18
PCT/JP2002/004768 WO2002094274A1 (en) 2001-05-18 2002-05-17 Cathartic composition

Publications (3)

Publication Number Publication Date
JP2004529960A JP2004529960A (ja) 2004-09-30
JP2004529960A5 true JP2004529960A5 (enExample) 2005-12-22
JP4597481B2 JP4597481B2 (ja) 2010-12-15

Family

ID=23121127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002590991A Expired - Lifetime JP4597481B2 (ja) 2001-05-18 2002-05-17 下剤組成物

Country Status (18)

Country Link
US (2) US6956056B2 (enExample)
EP (1) EP1389116B1 (enExample)
JP (1) JP4597481B2 (enExample)
KR (1) KR100867295B1 (enExample)
CN (1) CN1273140C (enExample)
AR (3) AR035242A1 (enExample)
AT (1) ATE387204T1 (enExample)
AU (1) AU2002307725B2 (enExample)
BR (1) BR0209863A (enExample)
CA (1) CA2445651C (enExample)
DE (1) DE60225266T2 (enExample)
DK (1) DK1389116T3 (enExample)
ES (1) ES2301681T3 (enExample)
MX (1) MXPA03010510A (enExample)
NZ (1) NZ529406A (enExample)
PT (1) PT1389116E (enExample)
TW (2) TWI324589B (enExample)
WO (1) WO2002094274A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
AU2003274735B2 (en) * 2002-10-23 2008-12-04 Sucampo Ag Prostaglandin compounds for the treatment of obesity
EP2281564A3 (en) 2002-12-27 2012-09-05 Sucampo AG Derivatives of prostaglandins for treating abdominal discomfort
US7049319B2 (en) 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
TWI387454B (zh) 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US20070071793A1 (en) * 2005-09-23 2007-03-29 Leon Clark Cure for prostate enlargement frequency of urination and cancer
CN101379051B (zh) * 2006-02-07 2014-05-28 株式会社·R-技术上野 用于制备前列腺素衍生物的方法
CN102050808B (zh) * 2009-11-02 2014-03-12 上海天伟生物制药有限公司 一种前列腺素中间体的制备方法
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
WO2018065826A1 (en) 2016-10-06 2018-04-12 Sucampo Ag Multilayer beads for pharmaceutical use
US10457623B1 (en) * 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1396206A (en) * 1972-04-27 1975-06-04 Upjohn Co Prostaglandins and the preparation thereof
ZA744581B (en) * 1973-07-20 1975-07-30 Upjohn Co Prostoglandin analogs
US3969376A (en) * 1973-07-20 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
US3969381A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
US3969379A (en) * 1975-02-21 1976-07-13 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin A1 analogs
GB8305697D0 (en) * 1983-03-02 1983-04-07 Erba Farmitalia Pharmaceutical compositions
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
JPH0681728B2 (ja) * 1987-10-02 1994-10-19 株式会社上野製薬応用研究所 下 剤
EP0310305B1 (en) * 1987-10-02 1992-07-22 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Cathartics
JP2579193B2 (ja) 1988-07-19 1997-02-05 小野薬品工業株式会社 16,16−ジフルオロ−15−オキソ−15−デオキシpge誘導体
EP0455448B1 (en) 1990-05-01 1998-12-09 R-Tech Ueno Ltd. Treatment of pancreatic disease with 15-keto-prostaglandin E compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE141794T1 (de) * 1991-03-14 1996-09-15 R Tech Ueno Ltd Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
JP3183615B2 (ja) * 1994-06-03 2001-07-09 株式会社アールテック・ウエノ 肝・胆道系疾患処置剤
CN101085756B (zh) * 1996-06-10 2011-03-02 苏坎波公司 内皮素拮抗剂
JP4786866B2 (ja) * 2001-08-31 2011-10-05 スキャンポ・アーゲー クロライドチャンネルオープナーとしてのプロスタグランジンアナログ

Similar Documents

Publication Publication Date Title
JP2004529960A5 (enExample)
JP2004527567A5 (enExample)
JP2005504836A5 (enExample)
JP2008531468A5 (enExample)
KR100349964B1 (ko) ω-시클로알킬 프로스타글란딘 E1 유도체
JP2004507521A5 (enExample)
AR110149A2 (es) Composición catártica
KR20000070903A (ko) 11,15-o-디알킬프로스타글란딘 e 유도체, 이것의 제조 방법 및 이것을 유효 성분으로 함유하는 약제
JP2006513232A5 (enExample)
RU2382026C2 (ru) Аналоги липоксина а4
JP2002541233A5 (enExample)
JP2010514786A5 (enExample)
RU2001122114A (ru) 4-(гетероциклилсульфонамидо)-5-метокси-6-(2-метоксифенокси)-2-фенил- или пиридилпиримидины в качестве антагонистов рецептора эндотелина
KR20100092909A (ko) 잔틴 옥시다제 저해제로서 효과적인 신규 화합물, 그 제조방법 및 그를 함유하는 약제학적 조성물
CA2377661A1 (en) Use of fatty acid derivative for the treatment of external secretion disorders
TW209170B (enExample)
JP2010505865A5 (enExample)
JP2006515866A5 (enExample)
JP2006506381A5 (enExample)
JP2005536531A5 (enExample)
JP2004519412A5 (enExample)
KR900016098A (ko) 카페인산의 유도체 및 이를 함유하는 약제학적 조성물
JP2012516347A5 (enExample)
JP2007518685A5 (enExample)
JP2010502568A5 (enExample)